Definitive concomitant chemoradiotherapy with docetaxel and cisplatin in squamous esopheageal carcinoma
Author:
Publisher
Oxford University Press (OUP)
Subject
Gastroenterology,General Medicine
Link
http://academic.oup.com/dote/article-pdf/23/3/253/10395658/dote0253.pdf
Reference34 articles.
1. Therapeutic strategies in oesophageal carcinoma: role of surgery and other modalities;Mariette;Lancet Oncol,2007
2. Systemic treatment for oesophageal cancer;van Meerten;Eur J Cancer,2005
3. Combined chemoradiotherapy vs. radiotherapy alone for early stage squamous cell carcinoma of the esophagus: a study of the Eastern Cooperative Oncology Group;Smith;Int J Radiat Oncol Biol Phys,1998
4. Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an intergroup study;Al-Sarraf;J Clin Oncol,1997
5. Combined chemotherapy and radiotherapy (without surgery) compared with radiotherapy alone in localized carcinoma of the esophagus (Cochrane Review);Wong;Cochrane Database Syst Rev,2001
Cited by 67 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Induction Therapy of Tislelizumab Combined with Cisplatin and 5-Fluorouracil and Subsequent Conversion Surgery in Patients with Unresectable Advanced Esophageal Squamous Cell Carcinoma: A Phase 2, Single Center Study;Annals of Surgical Oncology;2024-08-23
2. Current and future on definitive concurrent chemoradiotherapy for inoperable locally advanced esophageal squamous cell carcinoma;Frontiers in Oncology;2024-01-26
3. Unveiling Therapeutic Targets for Esophageal Cancer: A Comprehensive Review;Current Oncology;2023-10-30
4. Definitive concurrent chemoradiotherapy with docetaxel plus cisplatin versus 5-fluorouracil plus cisplatin in patients with esophageal squamous cell carcinoma: long-term follow-up results of a phase II randomized controlled trial;Radiation Oncology;2023-09-12
5. Moderately hypo-fractionated radiotherapy combined with S-1 in inoperable locally advanced esophageal squamous cell carcinoma: A prospective, single-arm phase II study (GASTO-1045);Frontiers in Oncology;2023-03-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3